The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary

low level resistance

Mar 28, 2007

1.Can a norvir/atanazavir/truvada regimen be successful in a treatment naive patient if there are mutations that cause low level resistance to Viread?

2.Is there a regimen for the same individual who is resistant to all nnrti and most nrti meds but no resistance to PI meds?

Response from Dr. Young

Thanks for your post.

1) Yes, the regimen can be successful, but I have to wonder why one would select a tenofovir (Viread, part of Truvada)-based regimen in the presence of resistance. I'd look to other, fully potent nuke options if these were viable options-- the DHHS and IAS treatment guidelines point to the use of AZT/3TC (Combivir) or abacavir/3TC (Epzicom, Kivexa) as other options.

2) Yes, if there's significant resistance to nukes and non-nukes, there are treatment possibilities- definitely a regimen that included a ritonavir (Norvir)-boosted protease inhibitor, perhaps with a recycled nuke, T20 (Fuzeon) or one of the newer investigational drugs, such as maraviroc or raltegravir.


VL=0 ?
Strange situation

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint